MSD Antimicrobial Stewardship Program

Program Objectives

The Antibiotic Stewardship Program was initiated by MSD India in the year 2008. Antimicrobial stewardship program (AMS) is an attempt to rationalize the use of antimicrobials in the hospital setup by focusing on treatment guidelines based on local microbiology data of the hospital coupled with established principles of antimicrobial stewardship.

So far MSD has rolled out this program in more than 500 hospitals across more than 26 countries including India, Russia, Colombia, Vietnam, Philippines and Brazil. So far MSD has rolled out this program in more than 500 hospitals across more than 26 countries including India, Russia, Colombia, Vietnam, Philippines and Brazil. Copyright MSD

What are the health needs and challenges?

Antibiotic resistance occurs even with proper use of antibiotics, but widespread, inappropriate use accelerates resistance. In more developed countries, there are a number of contributing factors, such as over-the-counter sales of antibiotics, poor patient compliance, inappropriate selection of antibiotics and over prescribing. In less developed markets the situation is made worse by the prevalence of substandard medicines.

Description of partnership activities and how they address needs and challenges

The most significant achievement of the project was that it made available to the scientific community a patient/physician friendly format of AMS which can be rolled out in day to day clinical practice at the patient bedside even with basic minimum resources at their disposal. So far MSD has rolled out this program in more than 500 hospitals across more than 26 countries including India, Russia, Colombia, Vietnam, Philippines and Brazil to develop AMS plans, resulting in the training of 10,000+ healthcare providers and implementation of 400+ locally tailored treatment pathways.  In future we plan to expand the program further in Latin America, China, Korea and Europe. Importantly MSD plans to measure clinical outcomes in those institutions where this program is rolled out and assess what clinical, cost and resistance benefits have been achieved. An AMS Mobile App was also launched in India to offer point of care AMS solutions in many Indian hospitals.

Corresponding principle in Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance

We are committed to antibiotics only being used in patients who need them, we support continued education for clinical professionals on appropriate use, and we welcome the WHO Global Action Plan’s focus on improved stewardship. 

Read full Declaration by the Pharmaceutical, Biotechnology and Diagnostics Industries on Combating Antimicrobial Resistance (AMR)

Videos

e-AMS to help control antimicrobial resistance | Q&A

Partnership information

Therapeutic Focus Infectious Diseases

Disease(s) Drug-Resistant Infections (AMR)

Program Type(s) Health System Infrastructure - Training

Region(s) East Asia & Pacific, Europe & Central Asia, Latin America & Caribbean, South Asia, Sub-Saharan Africa

Number of Countries 7

Country(ies) Brazil, Colombia, India, Philippines, Russia, South Africa, Vietnam

Start Date 2008

More information MSD on Antibiotics Antimicrobial Stewardship (AMS)

Anticipated completion date Ongoing